Spark Investment Management LLC Mersana Therapeutics, Inc. Transaction History

Spark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.54 - $4.2 $164,890 - $449,702	-107,072 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$3.84 - $6.4 $208,404 - $347,340	54,272 Added 102.79%	107,072 $433,000
Q1 2019 May 07, 2019	BUY	$3.51 - $7.3 $12,636 - $26,280	3,600 Added 7.32%	52,800 $277,000
Q4 2018 Feb 12, 2019	BUY	$3.45 - $9.72 $169,740 - $478,224	49,200 New	49,200 $200,000
Q2 2018 Aug 08, 2018	SELL	$14.2 - $22.68 $353,991 - $565,389	-24,929 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$13.56 - $18.48 $161,757 - $220,447	11,929 Added 91.76%	24,929 $393,000
Q4 2017 Feb 12, 2018	SELL	$14.95 - $19.9 $85,035 - $113,191	-5,688 Reduced 30.44%	13,000 $213,000
Q3 2017 Nov 13, 2017	BUY	$14.8 - $18.06 $276,582 - $337,505	18,688	18,688 $323,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.